Full CoverageTop news
An FDA panel supports Merck COVID drug in mixed vote
By Scott Hensley
As Antiviral Pills Arrive, Can Testing Keep Up? (Published 2021)
By Emily Anthes
US panel backs first-of-a-kind COVID-19 pill from Merck
By Matthew Perrone
FDA advisory panel narrowly endorses Merck's oral Covid treatment pill, despite reduced efficacy and safety questions
By Spencer Littleford Kimball
All coverage
FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19
By Matthew Herper
U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill
By Michael Erman & Manas Mishra
FDA advisory panel narrowly recommends Merck’s Covid pill for emergency use
By Berkeley Lovelace Jr.
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel (Published 2021)
By Rebecca Robbins & Carl Zimmer